health FDA Reverses Huntington’s Gene Therapy Block Following Leadership Change
UniQure’s AMT-130 gene therapy for Huntington’s disease regains approval pathway after FDA drops controversial sham surgery requirement previously mandated by former regulator Vinay Prasad.
